William R Hunt
Overview
Explore the profile of William R Hunt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swenson C, Hunt W, Manfredi C, Beltran D, Hong J, Davis B, et al.
PLoS One
. 2025 Feb;
20(2):e0316721.
PMID: 39951444
Background: Non-cystic fibrosis bronchiectasis (NCFBE) is a disease that exhibits dilatation of airways, airflow obstruction, persistent cough, excessive sputum production, and refractory respiratory infections. NCFBE exhibits clinical and pathological manifestations...
2.
Lertdetkajorn K, Cobb C, Kapolka R, Hunt W, Tangpricha V
AACE Clin Case Rep
. 2025 Feb;
11(1):32-35.
PMID: 39896950
Background/objective: Men with cystic fibrosis (CF) have a high prevalence of low testosterone levels. A recent retrospective study demonstrated a quarter of a cohort of men with CF had serum...
3.
Zaveri S, Stecenko A, Hunt W, Goss A, Sharma P, Hartman T, et al.
BMJ Open
. 2024 Dec;
14(12):e092503.
PMID: 39725418
Introduction: People with cystic fibrosis (PwCF) are at high risk for developing cystic fibrosis (CF)-related diabetes (CFRD), which worsens morbidity and mortality. Although the pathological events leading to the development...
4.
Perception and participation in sport and exercise in cystic fibrosis: The impact of CFTR modulators
Berthold A, Barr E, Kasi A, Lichten L, Hunt W
Respir Med
. 2024 Oct;
235:107840.
PMID: 39481659
Background: People with cystic fibrosis (pwCF) have barriers to physical activity including exercise intolerance and fatigue. The advent of small molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulators have shown...
5.
Solomon G, Linnemann R, Rich R, Streby A, Buehler B, Hunter E, et al.
Lancet Respir Med
. 2024 Aug;
12(12):947-957.
PMID: 39208836
Background: CFTR modulators are approved for approximately 90% of people with cystic fibrosis in the USA and provide substantial clinical benefit. N1303K (Asn1303Lys), one of the most common class 2...
6.
Suppakitjanusant P, Wang Y, Sivapiromrat A, Hu C, Binongo J, Hunt W, et al.
J Clin Transl Endocrinol
. 2024 Aug;
37:100362.
PMID: 39188269
Background: Cystic fibrosis (CF) is a multi-organ disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Individuals with CF often have gastrointestinal (GI) dysbiosis due to chronic...
7.
Jathal I, Wang Y, Binongo J, Cobb C, Hunt W, Khan F, et al.
Am J Med Sci
. 2024 Jul;
368(6):637-647.
PMID: 38997066
Background: Men with cystic fibrosis (CF) have sexual health concerns such as delayed puberty, infertility, and hypogonadism. The causes and prevalence of hypogonadism have not been well studied. The purpose...
8.
Sivapiromrat A, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt W, et al.
Contemp Clin Trials Commun
. 2024 Mar;
38:101278.
PMID: 38435430
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
9.
Sivapiromrat A, Suppakitjanusant P, Wang Y, Binongo J, Hunt W, Gewirtz A, et al.
medRxiv
. 2024 Feb;
PMID: 38343811
Individuals with cystic fibrosis (CF) have dysfunctional intestinal microbiota and increased gastrointestinal (GI) inflammation also known as GI dysbiosis. It is hypothesized that administration of high-dose cholecalciferol (vitamin D) together...
10.
Sivapiromrat A, Hunt W, Alvarez J, Ziegler T, Tangpricha V
medRxiv
. 2024 Feb;
PMID: 38343807
Individuals with cystic fibrosis (CF) often incur damage to pancreatic tissue due to a dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein, leading to altered chloride transport on epithelial surfaces...